These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 16935391

  • 1. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer.
    Han JY, Choi BG, Choi JY, Lee SY, Ju SY.
    Lung Cancer; 2006 Nov; 54(2):227-34. PubMed ID: 16935391
    [Abstract] [Full Text] [Related]

  • 2. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E, Köksal D, Yurdakul AS, Atikcan S, Cinaz P.
    Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
    [Abstract] [Full Text] [Related]

  • 3. [Non-small-cell bronchial carcinoma--prognostic value of IGF protein].
    Klein F.
    Pneumologie; 2007 Oct; 61(10):625. PubMed ID: 17922382
    [No Abstract] [Full Text] [Related]

  • 4. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S, Vitelli G, Mirabelli R, Digiesu G, Giannarelli D, Cuneo A, Ribatti D, Vacca A.
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.
    Chang YS, Kong G, Sun S, Liu D, El-Naggar AK, Khuri FR, Hong WK, Lee HY.
    Clin Cancer Res; 2002 Dec; 8(12):3796-802. PubMed ID: 12473592
    [Abstract] [Full Text] [Related]

  • 6. Serum insulin-like growth factor binding protein-3/prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer.
    Miyata Y, Sakai H, Hayashi T, Kanetake H.
    Prostate; 2003 Feb 01; 54(2):125-32. PubMed ID: 12497585
    [Abstract] [Full Text] [Related]

  • 7. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.
    Chang YS, Wang L, Liu D, Mao L, Hong WK, Khuri FR, Lee HY.
    Clin Cancer Res; 2002 Dec 01; 8(12):3669-75. PubMed ID: 12473575
    [Abstract] [Full Text] [Related]

  • 8. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.
    Oh JC, Wu W, Tortolero-Luna G, Broaddus R, Gershenson DM, Burke TW, Schmandt R, Lu KH.
    Cancer Epidemiol Biomarkers Prev; 2004 May 01; 13(5):748-52. PubMed ID: 15159305
    [Abstract] [Full Text] [Related]

  • 9. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR, Barnett MJ, Goodman GE, Thornquist MD, Wu X, Pollak M.
    Cancer Epidemiol Biomarkers Prev; 2002 Nov 01; 11(11):1413-8. PubMed ID: 12433720
    [Abstract] [Full Text] [Related]

  • 10. [Significance and expression of insulin-like growth factor 1 and IGF binding protein 3 in serum of patients with lung cancer].
    Wang H, Wan YX, Zhang QK.
    Ai Zheng; 2004 Jun 01; 23(6):710-4. PubMed ID: 15191678
    [Abstract] [Full Text] [Related]

  • 11. Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.
    Decensi A, Veronesi U, Miceli R, Johansson H, Mariani L, Camerini T, Di Mauro MG, Cavadini E, De Palo G, Costa A, Perloff M, Malone WF, Formelli F.
    Clin Cancer Res; 2003 Oct 15; 9(13):4722-9. PubMed ID: 14581342
    [Abstract] [Full Text] [Related]

  • 12. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer.
    Renehan AG, Jones J, Potten CS, Shalet SM, O'Dwyer ST.
    Br J Cancer; 2000 Nov 15; 83(10):1344-50. PubMed ID: 11044360
    [Abstract] [Full Text] [Related]

  • 13. The relationship between the insulin-like growth factor-1 axis, weight loss, an inflammation-based score and survival in patients with inoperable non-small cell lung cancer.
    Meek CL, Wallace AM, Forrest LM, McMillan DC.
    Clin Nutr; 2010 Apr 15; 29(2):206-9. PubMed ID: 19748165
    [Abstract] [Full Text] [Related]

  • 14. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer.
    Serrano ML, Romero A, Cendales R, Sánchez-Gómez M, Bravo MM.
    Biomedica; 2006 Jun 15; 26(2):258-68. PubMed ID: 16925098
    [Abstract] [Full Text] [Related]

  • 15. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer.
    Kim YH, Sumiyoshi S, Hashimoto S, Masago K, Togashi Y, Sakamori Y, Okuda C, Mio T, Mishima M.
    Clin Lung Cancer; 2012 Sep 15; 13(5):385-90. PubMed ID: 22285568
    [Abstract] [Full Text] [Related]

  • 16. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.
    Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Risch HA, Puopolo M, Yu H.
    Clin Cancer Res; 2006 Feb 15; 12(4):1208-14. PubMed ID: 16489075
    [Abstract] [Full Text] [Related]

  • 17. [Expression and prognostic significance in epithelial ovarian cancer].
    Katsaros D, Yu H, Piccinno R, Puopolo M, Rigault De La Longrais IA, Fracchioli S, Massobrio M.
    Minerva Ginecol; 2002 Feb 15; 54(1):15-24. PubMed ID: 11828267
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins.
    Lawrence JB, Conover CA, Haddad TC, Ingle JN, Reid JM, Ames MM, Suman VJ, Marks RS, Erlichman C, Hartmann LC.
    Clin Cancer Res; 1997 Oct 15; 3(10):1713-20. PubMed ID: 9815555
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of IGF-I and IGF-II in patients with lung cancer during chemotherapy.
    Izycki T, Chyczewska E, Naumnik W, Talalaj J, Panek B, Ossolinska M.
    Exp Oncol; 2004 Dec 15; 26(4):316-9. PubMed ID: 15627066
    [Abstract] [Full Text] [Related]

  • 20. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
    Schoen RE, Weissfeld JL, Kuller LH, Thaete FL, Evans RW, Hayes RB, Rosen CJ.
    Gastroenterology; 2005 Aug 15; 129(2):464-75. PubMed ID: 16083703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.